Financials Bio-Gene Technology Limited

Equities

BGT

AU000000BGT8

Agricultural Chemicals

Market Closed - Australian S.E. 06:14:36 07/05/2024 BST 5-day change 1st Jan Change
0.06 AUD -13.04% Intraday chart for Bio-Gene Technology Limited -13.04% 0.00%

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 21.07 11.61 19.65 26.12 23.15 13.88
Enterprise Value (EV) 1 14.37 7.111 14.13 22.18 16.8 10.89
P/E ratio -6.85 x -5.14 x -8.02 x -9.71 x -6.84 x -4.22 x
Yield - - - - - -
Capitalization / Revenue 44.4 x 18 x 160 x 417 x 51.9 x 93 x
EV / Revenue 30.3 x 11 x 115 x 354 x 37.7 x 72.9 x
EV / EBITDA -5.77 x -3.54 x -6.89 x -9.27 x -5.75 x -3.47 x
EV / FCF -8.63 x -4.95 x -14 x -22.6 x -19.1 x -4.82 x
FCF Yield -11.6% -20.2% -7.12% -4.42% -5.23% -20.7%
Price to Book 3.05 x 2.35 x 3.27 x 6.15 x 3.71 x 4.31 x
Nbr of stocks (in thousands) 127,724 129,008 151,116 153,633 178,047 177,906
Reference price 2 0.1650 0.0900 0.1300 0.1700 0.1300 0.0780
Announcement Date 22/08/18 22/08/19 26/08/20 26/08/21 15/08/22 31/07/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 0.4745 0.6446 0.1228 0.0626 0.4457 0.1492
EBITDA 1 -2.492 -2.01 -2.051 -2.392 -2.924 -3.136
EBIT 1 -2.534 -2.056 -2.096 -2.434 -2.967 -3.182
Operating Margin -533.91% -318.89% -1,707.19% -3,887.62% -665.67% -2,132.08%
Earnings before Tax (EBT) 1 -2.833 -2.056 -1.933 -2.396 -2.914 -3.096
Net income 1 -2.833 -2.056 -1.933 -2.396 -2.914 -3.096
Net margin -597.03% -318.89% -1,574.25% -3,827.29% -653.81% -2,074.48%
EPS 2 -0.0241 -0.0175 -0.0162 -0.0175 -0.0190 -0.0185
Free Cash Flow 1 -1.664 -1.438 -1.007 -0.9814 -0.8786 -2.259
FCF margin -350.7% -223.01% -819.9% -1,567.5% -197.12% -1,513.56%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 22/08/18 22/08/19 26/08/20 26/08/21 15/08/22 31/07/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: Giugno 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 6.71 4.5 5.51 3.93 6.34 2.99
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.66 -1.44 -1.01 -0.98 -0.88 -2.26
ROE (net income / shareholders' equity) -57.7% -34.7% -35.3% -46.8% -55.4% -65.2%
ROA (Net income/ Total Assets) -28.3% -19.4% -21.6% -26.3% -30.1% -35.7%
Assets 1 10 10.58 8.95 9.113 9.668 8.67
Book Value Per Share 2 0.0500 0.0400 0.0400 0.0300 0.0400 0.0200
Cash Flow per Share 2 0.0500 0.0300 0.0400 0.0300 0.0400 0.0200
Capex 1 0.01 0 - 0 0.01 -
Capex / Sales 2.84% 0.42% - 4.84% 1.53% -
Announcement Date 22/08/18 22/08/19 26/08/20 26/08/21 15/08/22 31/07/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGT Stock
  4. Financials Bio-Gene Technology Limited